Prevalence and Factors of Influenza Vaccination During the COVID-19 Pandemic Among University Students in China
Overview
Authors
Affiliations
Background: Previous outbreaks of emerging infectious diseases (e.g., SARS) had increased the uptake of influenza vaccination (IV). It is uncertain whether such was also true for COVID-19. This study hence investigated prevalence of IV behavior/intention prior to and during the COVID-19 pandemic and associated cognitive factors.
Methods: A self-administered, online, and anonymous cross-sectional survey was conducted among 6,922 university students of five provinces in China during November 1-28, 2020 (response rate: 72.3%).
Results: Of all the participants, 35.1% self-reported behavioral intention of IV (next 12 months), while 62.9% reported an increased intention of IV due to COVID-19. However, only 4.7% and 2.9% had taken up IV during the 12-month period prior to the outbreak (1/2019-12/2019) and during the COVID-19 outbreak (1-11/2020), respectively. Adjusted for the background factors, the multivariable logistic regression analysis showed that in general the COVID-19 related perceptions (perceived susceptibility, perceived severity, and perceived chance of having another wave of COVID-19 outbreak) were significantly and positively associated the IV behavior (during the COVID-19 outbreak) and intention of IV uptake in the next 12 months.
Conclusions: The COVID-19 pandemic may have influenced actual behavior and intention of IV uptake among university students during the pandemic. Efforts are warranted to reduce the intention-behavior gap of IV uptake; modification of perceived susceptibility and perceived severity regarding COVID-19 may help. Future longitudinal and intervention studies are needed to confirm the findings of this study and explore other factors affecting IV uptake during the COVID-19 period.
Impact of COVID-19 on vaccine confidence and uptake: A systematic literature review.
Vojtek I, van Wouw M, Thomson A Hum Vaccin Immunother. 2024; 20(1):2384180.
PMID: 39106971 PMC: 11305033. DOI: 10.1080/21645515.2024.2384180.
Sun G, Zhang L, Qiu Y, Jia Y, Wang Y, Xu H Hum Vaccin Immunother. 2024; 20(1):2287294.
PMID: 38299510 PMC: 10841022. DOI: 10.1080/21645515.2023.2287294.
Guo M, Li J, Wang Y, Chen G, Chen R, Wang L Hum Vaccin Immunother. 2023; 19(3):2275464.
PMID: 37941303 PMC: 10653700. DOI: 10.1080/21645515.2023.2275464.
Kwon K, Bae K, Park J, Kim T, Kim J, Baek S Asia Pac J Public Health. 2023; 35(2-3):217-220.
PMID: 37171247 PMC: 10009003. DOI: 10.1177/10105395231160917.
Zou H, Huang Y, Chen T, Zhang L Ann Med. 2023; 55(1):2195206.
PMID: 37102623 PMC: 10142317. DOI: 10.1080/07853890.2023.2195206.